Michael Kalb

Director of Finance/CFO presso CATALYST PHARMACEUTICALS, INC.

53 anni

Health Technology

Commercial Services

Consumer Services

Profilo

Michael W.
Kalb is currently the Chief Financial Officer & Executive Vice President at Catalyst Pharmaceuticals, Inc. He previously held positions as the Director-Accounting & Financial Consulting Group at Huron Consulting Group, Inc., Chief Financial Officer & Senior Vice President at Amarin Corp.
Plc, Chief Financial & Accounting Officer, Group VP at Taro Pharmaceutical Industries Ltd., Chief Financial Officer at Ipi Legacy Liquidation Co., Chief Financial Officer at Taro Pharmaceuticals U.S.A., Inc., and Executive VP, Chief Financial & Accounting Officer at CinCor Pharma, Inc. He obtained his undergraduate degree from the State University of New York at Albany.

Posizioni attive di Michael Kalb

Società	Posizione	Inizio
CATALYST PHARMACEUTICALS, INC.	Director of Finance/CFO	01/01/2024

Tutte le posizioni attive di Michael Kalb

Precedenti posizioni note di Michael Kalb

Società	Posizione	Fine
IPI LEGACY LIQUIDATION CO	Director of Finance/CFO	31/12/2023
CINCOR PHARMA, INC.	Director of Finance/CFO	01/03/2023
AMARIN CORPORATION PLC	Director of Finance/CFO	20/06/2022
TARO PHARMACEUTICAL INDUSTRIES LTD.	Director of Finance/CFO	29/06/2016
HURON CONSULTING GROUP INC.	Comptroller/Controller/Auditor	-

Vedi nel dettaglio l'esperienza di Michael Kalb

Formazione di Michael Kalb

State University of New York at Albany

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael Kalb

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	5
AMARIN CORPORATION PLC	Health Technology
TARO PHARMACEUTICAL INDUSTRIES LTD.	Health Technology
HURON CONSULTING GROUP INC.	Commercial Services
CATALYST PHARMACEUTICALS, INC.	Health Technology
IPI LEGACY LIQUIDATION CO	Health Technology

Aziende private	2
Taro Pharmaceuticals U.S.A., Inc. Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a private company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY.	Health Technology
CinCor Pharma, Inc. CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA.	Health Technology

Aziende private